Five departments, one common goal:For the past 100 years, the Max‐Planck‐Institut für Kohlenforschung in Mülheim an der Ruhr has focused above all on chemical catalysis, and this is more true today than ever. Researchers in heterogeneous, homogeneous, and biocatalysis, organometallic chemistry, organic synthesis, as well as theoretical chemistry are occupied with the catalytic transformation of raw materials and pure compounds with the highest possible chemo‐, regio‐, and stereoselectivity under conditions that maximize the use of natural resources. [ABSTRACT FROM AUTHOR]
BUSINESS partnerships, PHARMACEUTICAL chemistry, DRUG development, NATURAL products, and BUSINESS enterprises
Abstract
The article presents the author's views on the increasing partnership between academic and industrial enterprises of pharmaceuticals with an aim of improving drug discovery and development. Various issues discussed includes challenges faced by academic-industrial partnerships, structure of medicinal chemistry, organic synthesis and use of natural products in drug development.
